Mandibulofacial dysostosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:155899Q75.4
Who is this for?
Show terms as
11Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mandibulofacial dysostosis, also known as Treacher Collins syndrome (TCS) or Treacher Collins-Franceschetti syndrome, is a rare genetic disorder that primarily affects the development of bones and other tissues of the face. The condition is present at birth and results from abnormal development of the first and second pharyngeal arches during early embryonic growth. Key clinical features include underdevelopment of the facial bones, particularly the mandible (lower jaw) and zygomatic bones (cheekbones), giving the face a characteristic appearance with a small jaw (micrognathia) and flattened cheeks. Patients frequently have downward-slanting palpebral fissures (eye openings), colobomas (notches) of the lower eyelids, and sparse or absent eyelashes on the lower lids. The external ears are often malformed, small, or absent (microtia or anotia), and conductive hearing loss is common due to abnormalities of the middle ear ossicles and external auditory canals. The severity of mandibulofacial dysostosis varies widely, even among affected members of the same family, ranging from mild cases that may go undiagnosed to severe presentations with significant airway compromise requiring urgent intervention at birth. Cleft palate occurs in approximately one-third of affected individuals. Intelligence is typically normal. The condition primarily affects the craniofacial skeleton, the eyes, and the auditory system. Treatment is multidisciplinary and symptomatic, as there is no cure. Management may include surgical reconstruction of the facial bones, jaw, and ears; hearing aids or bone-anchored hearing devices to address hearing loss; cleft palate repair; and orthodontic treatment. In severe cases, tracheostomy or mandibular distraction osteogenesis may be necessary to secure the airway in the neonatal period. Speech therapy and psychosocial support are also important components of care. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mandibulofacial dysostosis.

View clinical trials →

No actively recruiting trials found for Mandibulofacial dysostosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mandibulofacial dysostosis community →

Specialists

11 foundView all specialists →
MP
Matthew L Speltz, PhD
SEATTLE, WA
Specialist
PI on 1 active trial
CM
Carrie L Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
BB
Barbara B Biesecker
CLARKS SUMMIT, PA
Specialist
PI on 16 active trials
MP
Mark Sun, PhD
COON RAPIDS, MN
Specialist
PI on 1 active trial
YM
yasser el hadidi, mds
Specialist
PI on 1 active trial
CD
Caroline ROORYCK THAMBO, Dr
Specialist
PI on 1 active trial
CM
Carrie Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
DM
Daniela Y Tanikawa, MD
Specialist
PI on 1 active trial
AP
Azra Mehmood, PhD
Specialist
PI on 1 active trial
SP
Sheikh Riazuddin, PhD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mandibulofacial dysostosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mandibulofacial dysostosisForum →

No community posts yet. Be the first to share your experience with Mandibulofacial dysostosis.

Start the conversation →

Latest news about Mandibulofacial dysostosis

No recent news articles for Mandibulofacial dysostosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mandibulofacial dysostosis

What is Mandibulofacial dysostosis?

Mandibulofacial dysostosis, also known as Treacher Collins syndrome (TCS) or Treacher Collins-Franceschetti syndrome, is a rare genetic disorder that primarily affects the development of bones and other tissues of the face. The condition is present at birth and results from abnormal development of the first and second pharyngeal arches during early embryonic growth. Key clinical features include underdevelopment of the facial bones, particularly the mandible (lower jaw) and zygomatic bones (cheekbones), giving the face a characteristic appearance with a small jaw (micrognathia) and flattened c

How is Mandibulofacial dysostosis inherited?

Mandibulofacial dysostosis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mandibulofacial dysostosis typically begin?

Typical onset of Mandibulofacial dysostosis is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Mandibulofacial dysostosis?

11 specialists and care centers treating Mandibulofacial dysostosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.